Lyka Labs Share Price
(LYKALABS)
₹118.41▲0.77%
as on 04:02PM, 21 Feb 2025
Lyka Labs Performance
Day's Low
Day's High
₹116.78Day's Price Range₹119.9952 Week's Low
52 Week's High
₹97.952-Week Price Range₹176.59
| Returns % | |
| 1 Month Return | -22.81 % |
| 3 Month Return | -17.06 % |
| 1 Year Return | -7.02 % |
| Market Stats | |
| Previous Close | ₹117.51 |
| Open | ₹116.78 |
| Volume | 27.97K |
| Upper Circuit | - |
| Lower Circuit | - |
| Market Cap | ₹419.39Cr |
Lyka Labs Key Statistics
P/E Ratio
-55.96
PEG Ratio
65.07
Market Cap
₹419.39 Cr
P/B Ratio
3.88
EPS
-0.79
Dividend Yield
0Sector
Pharmaceuticals
ROE
0Key events for Lyka Labs Ltd
Lyka Labs Reports Strong Q3 Growth in Sales and Profit - 25 Nov, 2024
Lyka Labs reported a 47.05% increase in net sales to Rs 41.16 crore for September 2024, with net profit soaring 530.91% to Rs 2.10 crore. EBITDA rose 12.67%, and EPS increased to Rs 0.58. The stock has delivered 27.18% returns over the past six months.Lyka Labs Reports Strong Q3 Growth in Sales and Profit - 13 Nov, 2024
Lyka Labs reported a 53.79% increase in standalone net sales to Rs 41.16 crore for September 2024, with net profit soaring 946.01% to Rs 2.47 crore. EBITDA rose 29.01%, and EPS increased to Rs 0.69. The stock has delivered 28.05% returns over the last six months.
Insights on Lyka Labs Ltd
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTProfit Spike
Netprofit is up for the last 4 quarters, -2.13 Cr → 2.71 Cr (in ₹), with an average increase of 100.6% per quarter
NO EFFECTPromoter Holding Unchanged
Promoters holdings remained unchanged at 58.10% of holdings in Dec 2024 quarter
- NO EFFECT
FII Holding Unchanged
Foreign Institutions holdings remained unchanged at 0.15% of holdings in Dec 2024 quarter
- NO EFFECT
Retail Holding Unchanged
Retail Investor holdings remained unchanged at 41.08% of holdings in Dec 2024 quarter
- NO EFFECT
Against Peers
In the last 1 year, Divis Laboratories Ltd has given 57.9% return, outperforming this stock by 64.9%
- NO EFFECT
Against Peers
In the last 3 years, Torrent Pharmaceuticals Ltd has given 125.1% return, outperforming this stock by 136.5%
NEGATIVE IMPACTRevenue Fall
Revenue is down for the last 2 quarters, 41.18 Cr → 34.62 Cr (in ₹), with an average decrease of 15.9% per quarter
- NEGATIVE IMPACT
Price Dip
In the last 1 month, LYKALABS stock has moved down by -22.8%
Lyka Labs Financials
Lyka Labs Shareholding Pattern
| Investors | Holdings % | FY Quarter | 3M change |
|---|---|---|---|
| Promoter Holdings | 58.1% | 0.00 | |
| Foreign Institutions | 0.15% | 0.13 | |
| Mutual Funds | 0.01% | 0.00 | |
| Retail Investors | 41.08% | 0.00 | |
| Others | 0.66% | 0.00 |
Lyka Labs Key Indicators
Lyka Labs Valuation
Lyka Labs in the last 5 years
Lowest (-164.66x)
September 10, 2018
Today (-55.96x)
February 20, 2025
Industry (51.76x)
February 20, 2025
Highest (23.04x)
September 5, 2022
Lyka Labs Earnings and Dividends
Lyka Labs Ltd Earnings Results
Lyka Labs Ltd’s net profit jumped 52.25% since last year same period to ₹2.71Cr in the Q3 2024-2025. On a quarterly growth basis, Lyka Labs Ltd has generated 29.05% jump in its net profits since last 3-months.
Read More about Earnings Results
Lyka Labs Technicals Summary
Bearish
Neutral
Bullish
Lyka Labs Ltd is currently in a Bearish trading position according to technical analysis indicators.
Lyka Labs Peer Comparison
Company | Analyst View | Market Cap | 5 Year CAGR | Debt to Asset Ratio | Net Profit | Yearly Revenue |
|---|---|---|---|---|---|---|
| NA | ₹419.39 Cr | 110.48% | 0.69 | -₹3 Cr | ₹111 Cr | |
| NA | ₹181.11 Cr | -3.44% | 0.96 | NA | NA | |
| NA | ₹42.63 Cr | 6.79% | 0.58 | NA | NA | |
| NA | ₹2,091.41 Cr | 42.75% | 0.65 | -₹2 Cr | ₹559 Cr | |
| NA | ₹1,130.58 Cr | 43.88% | 0.50 | ₹93 Cr | ₹580 Cr |
About Lyka Labs
Share Price: ₹118.41 per share as on 21 Feb, 2025 04:02 PM
Market Capitalisation: ₹419.39Cr as of today
Revenue: ₹33.80Cr as on December 2024 (Q4 24)
Net Profit: ₹2.71Cr as on December 2024 (Q4 24)
Listing date: 08 Feb, 1995
Chairperson Name: KUNAL NARENDRA GANDHI
| Organisation | Lyka Labs |
| Headquarters | Mumbai |
| Industry | Pharmaceuticals |
| E-voting on shares | Click here to vote |
FAQs on Lyka Labs Ltd
What is Lyka Labs Ltd price today?
Lyka Labs Ltd share price today stands at ₹118.41, Open: ₹116.78, Previous Close: ₹117.51, High: ₹119.99, Low: ₹116.78, 52 Week High: ₹176.59, 52 Week Low: ₹97.9.
How to Buy Lyka Labs Ltd Share in India?
- Get a PAN card
- Open a Demat account
- Open a Trading account
- Link your Demat account to your Trading account
- Fund your Trading account
- Place an order to buy Lyka Labs Ltd shares
Is Lyka Labs Ltd listed on NSE?
Lyka Labs Ltd is listed on NSE
Is Lyka Labs Ltd listed on BSE?
Lyka Labs Ltd is listed on BSE
What are today's High and Low prices of Lyka Labs Ltd?
- Today's highest price of Lyka Labs Ltd is ₹119.99.
- Today's lowest price of Lyka Labs Ltd is ₹116.78.
What are today's traded volumes of Lyka Labs Ltd?
Today's traded volume of Lyka Labs Ltd(LYKALABS) is 27.97K.
What is today's market capitalisation of Lyka Labs Ltd?
Today's market capitalisation of Lyka Labs Ltd(LYKALABS) is ₹419.39Cr.
What is the 52 Week High and Low Range of Lyka Labs Ltd?
How much percentage Lyka Labs Ltd is down from its 52 Week High?
Lyka Labs Ltd (LYKALABS) share price is ₹118.41. It is down -32.95% from its 52 Week High price of ₹176.59
How much percentage Lyka Labs Ltd is up from its 52 Week low?
Lyka Labs Ltd (LYKALABS) share price is ₹118.41. It is up 20.95% from its 52 Week Low price of ₹97.9
What are the historical returns of Lyka Labs Ltd?
What is the PE ratio of Lyka Labs Ltd today?
PE Ratio of Lyka Labs Ltd is -55.96
PE ratio = Lyka Labs Ltd Market price per share / Lyka Labs Ltd Earnings per share